US Stock MarketDetailed Quotes

ZVSAW ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM)

Watchlist
  • 0.070
  • 0.0000.00%
Close Dec 20 16:00 ET
0Market Cap0.00P/E (TTM)

ZYVERSA THERAPEUTICS INC C/WTS 12/12/2027 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
0.66%-5.08M
-5.11M
Net income from continuing operations
36.26%-8.08M
---12.68M
Operating gains losses
-232.35%-441.58K
--333.66K
Depreciation and amortization
0.00%10.4K
--10.4K
Other non cash items
10.22%317.83K
--288.37K
Change In working capital
-132.81%-1.02M
--3.11M
-Change in prepaid assets
-127.61%-297.1K
--1.08M
-Change in payables and accrued expense
-135.56%-723.22K
--2.03M
Cash from discontinued investing activities
Operating cash flow
0.66%-5.08M
---5.11M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
14.69%5.23M
4.56M
Net issuance payments of debt
210.11%5.23M
--1.69M
Net common stock issuance
--0
--3M
Proceeds from stock option exercised by employees
--0
--15K
Net other financing activities
----
---141.4K
Cash from discontinued financing activities
Financing cash flow
14.69%5.23M
--4.56M
Net cash flow
Beginning cash position
-75.89%174.67K
--724.43K
Current changes in cash
128.00%153.91K
---549.76K
End cash Position
88.12%328.58K
--174.67K
Free cash flow
0.66%-5.08M
---5.11M
Currency Unit
USD
USD
(FY)Dec 31, 2021(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 0.66%-5.08M-5.11M
Net income from continuing operations 36.26%-8.08M---12.68M
Operating gains losses -232.35%-441.58K--333.66K
Depreciation and amortization 0.00%10.4K--10.4K
Other non cash items 10.22%317.83K--288.37K
Change In working capital -132.81%-1.02M--3.11M
-Change in prepaid assets -127.61%-297.1K--1.08M
-Change in payables and accrued expense -135.56%-723.22K--2.03M
Cash from discontinued investing activities
Operating cash flow 0.66%-5.08M---5.11M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 14.69%5.23M4.56M
Net issuance payments of debt 210.11%5.23M--1.69M
Net common stock issuance --0--3M
Proceeds from stock option exercised by employees --0--15K
Net other financing activities -------141.4K
Cash from discontinued financing activities
Financing cash flow 14.69%5.23M--4.56M
Net cash flow
Beginning cash position -75.89%174.67K--724.43K
Current changes in cash 128.00%153.91K---549.76K
End cash Position 88.12%328.58K--174.67K
Free cash flow 0.66%-5.08M---5.11M
Currency Unit USDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg